Form SC 13G/A Mersana Therapeutics, Filed by: BALYASNY ASSET MANAGEMENT L.P.

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/12/2026

1. ADBE
2. SPCX
3. USO
4. SPY
5. RH
6. NVDA
7. RKLB
8. CRWV
9. MSFT
10. MH

Go back to Form SC 13G/A Mersana Therapeutics, Filed by: BALYASNY ASSET MANAGEMENT L.P.

Citi Starts Mersana (MRSN) at Buy

November 15, 2024 4:52 AM EST

Citi analyst Yigal Nochomovitz initiates coverage on Mersana (NASDAQ: MRSN) with a Buy rating and a price target of $5.00.

The analyst comments "

MRSN expects to share initial data from the XMT-1660 (B7-H4 ADC) Ph1 by YE24. We see this readout as a... More